missing translation for 'onlineSavingsMsg'
Få mere at vide
  1. Home
  2. Products
  3. Kemikalier
  4. Organiske forbindelser
  5. Organoheterocykliske forbindelser
  6. Pyridiner og derivater
  7. Pexacerfont, MedChemExpress

Pexacerfont, MedChemExpress

Artikelnummer. 16437727
Encompass_Preferred
Skift visning
Klik for at se tilgængelige muligheder
Mængde:
5 mg
10 mg
2 product options available for selection
Product selection table with 2 available options. Use arrow keys to navigate and Enter or Space to select.
Product Code. Mængde
16437727 5 mg
16404998 10 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 2 options available.
2 options
This item is not returnable. View return policy
Product Code. 16437727 Supplier Medchem Express Supplier No. HY12127

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

MedChemExpress Pexacerfont is a selective corticotropin-releasing factor (CRF1) receptor antagonist with IC50 of 6.1±0.6 nM for human CRF1 receptor.

Pexacerfont is a selective corticotropin-releasing factor (CRF1) receptor antagonist with IC50 of 6.1±0.6 nM for human CRF1 receptor.

Specifications

Kemisk navn eller materiale Pexacerfont
CAS 459856-18-9
Farve White
Renhedsgrad noter Research
Molekylær formel C18H24N6O
Mængde 5 mg
Synonym BMS-562086
Opløselighedsinformation DMSO : 50 mg/mL (146.88 mM; Need ultrasonic)
SMIL CC[C@H](NC1=NC(C)=NC2=C(C3=CC=C(OC)N=C3C)C(C)=NN21)C
Molekylvægt (g/mol) 340.42
Formel vægt 340.42
Procent renhed 99.1%
Grad Research
Fysisk form Powder
Til brug med (applikation) Neuroscience-Neuromodulation
Show More Show Less

Research purposes only

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.